We have 3 of 4 papers
We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.
Not the right person? Other researchers publish under this name.
The potential of integrating CRISPR/Cas9 with nanodelivery systems to advance precision medicine for neuroinflammatory disorders, while emphasizing their potential for therapeutic applications in complex CNS conditions is highlighted.
Combining receptor-targeted nanomedicine with immunotherapeutic strategies could pave the way for personalized treatment regimens that improve therapeutic outcomes and survival in patients with gallbladder cancer.
In this review, recent progresses in biomimetic systems are summarized, such as cell membrane-coated nanoparticles, exosome-based carriers, and ligand-modified nanostructures, with a particular focus on their design paradigm and drug delivery mechanisms and the therapeutic potentiality in CC.
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.
